» Articles » PMID: 32090410

Cognitive Anosognosia is Associated with Frontal Dysfunction and Lower Depression in Parkinson's Disease

Overview
Journal Eur J Neurol
Publisher Wiley
Specialty Neurology
Date 2020 Feb 25
PMID 32090410
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Purpose: Anosognosia refers to a deficit of self-awareness or impaired insight for cognitive and behavioral problems. Cognitive anosognosia was explored in de novo patients with Parkinson's disease (PD) and its relationship to cognitive function and neuropsychiatric symptoms was investigated.

Methods: The cross-sectional study enrolled 340 drug-naïve patients with PD. According to the presence of mild cognitive impairment (MCI) and subjective cognitive complaint, patients were classified as patients with cognitive anosognosia (PD-CA, n = 74), with normal cognitive recognition (PD-NR, n = 184) or with cognitive underestimation (PD-CU, n = 82). After controlling for covariates, cognitive performance and neuropsychiatric symptoms were compared between the PD groups.

Results: Cognitive anosognosia was found in 21.8% of patients with de novo PD. The PD-CA group showed poorer performance in all cognitive domains except for attention. Amongst PD patients with MCI, those with cognitive anosognosia showed lower composite z-scores in the Stroop color reading test than those without. The Beck Depression Inventory score in the PD-NR group was lower than that in the PD-CU group and higher than that in the PD-CA group. The Cognitive Complaints Interview score mediated the association between cognitive anosognosia and Beck Depression Inventory score.

Conclusions: Cognitive anosognosia in PD was associated with greater frontal dysfunction and lower depression. Since cognitive anosognosia has a harmful impact on PD patients and their caregivers due to overestimation of their abilities in everyday life, early identification of cognitive anosognosia in PD is important in management and prognosis.

Citing Articles

Total burden of cerebral small vessel disease predict subjective cognitive decline in patients with Parkinson's disease.

Qiu W, Hu W, Ge Y, Liu P, Zhao M, Lu H Front Aging Neurosci. 2024; 16:1476701.

PMID: 39649721 PMC: 11621090. DOI: 10.3389/fnagi.2024.1476701.


Neurocognitive Impairment and Social Cognition in Parkinson's Disease Patients.

Doskas T, Vadikolias K, Ntoskas K, Vavougios G, Tsiptsios D, Stamati P Neurol Int. 2024; 16(2):432-449.

PMID: 38668129 PMC: 11054167. DOI: 10.3390/neurolint16020032.


Cognitive Self-Efficacy in Parkinson's Disease.

Jethani P, Toglia J, Foster E OTJR (Thorofare N J). 2023; 44(4):625-631.

PMID: 37905522 PMC: 11408982. DOI: 10.1177/15394492231206346.


Unawareness of Apathy in Parkinson's Disease: The Role of Executive Dysfunction on Symptom Recognition.

Maggi G, Vitale C, Delle Curti A, Amboni M, Santangelo G Brain Sci. 2023; 13(6).

PMID: 37371442 PMC: 10296387. DOI: 10.3390/brainsci13060964.


Accuracy of Machine Learning Using the Montreal Cognitive Assessment for the Diagnosis of Cognitive Impairment in Parkinson's Disease.

Jeon J, Kim K, Baek K, Chung S, Yoon J, Kim Y J Mov Disord. 2022; 15(2):132-139.

PMID: 35670022 PMC: 9171310. DOI: 10.14802/jmd.22012.